Base by Base
Base by Base explores advances in genetics and genomics, with a focus on gene-disease associations, variant interpretation, protein structure, and insights from exome and genome sequencing. Each episode breaks down key studies and their clinical relevance—one base at a time. Powered by AI, Base by Base offers a new way to learn on the go. Special thanks to authors who publish under CC BY 4.0, making open-access science faster to share and easier to explore.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(462)

453: Efavirenz slows sCJD progression by reshaping brain cholesterol

453: Efavirenz slows sCJD progression by reshaping brain cholesterol

Ali T et al., JCI Insight - Repurposed low-dose efavirenz slowed disease progression and extended survival in tg650 mice inoculated with MM1 sCJD prions by activating CYP46A1, raising 24S‑hydroxychole...

31 Elo 20min

452: Reduzir a PrP funciona em todas as linhagens [PT]

452: Reduzir a PrP funciona em todas as linhagens [PT]

Minikel EV et al., Nucleic Acids Research - Este estudo testa a redução da proteína priônica (PrP) por oligonucleotídeos antisense (ASOs) em camundongos, variando doses, esquemas de aplicação, linhage...

28 Elo 28min

451: Prion protein lowering is disease-modifying across stages and strains

451: Prion protein lowering is disease-modifying across stages and strains

Minikel EV et al., Nucleic Acids Research - This study uses antisense oligonucleotides (ASOs) to lower prion protein (PrP) RNA in mice and shows dose-dependent extension of survival, efficacy across m...

25 Elo 24min

450: ASOs que reduzem PrP prolongam a sobrevida [PT]

450: ASOs que reduzem PrP prolongam a sobrevida [PT]

Raymond GJ et al., JCI Insight - This episode covers a 2019 study showing that sequence-specific antisense oligonucleotides (ASOs) targeting the prion protein (PrP) mRNA, delivered by bolus intracereb...

24 Elo 24min

449: siRNA divalente para doença priônica [PT]

449: siRNA divalente para doença priônica [PT]

Gentile JE et al., Nucleic Acids Research - Discovery and preclinical development of divalent siRNA candidates targeting PRNP, identifying 2439-s4 as a potent, durable human PRNP-lowering drug candida...

24 Elo 28min

448: PrP‑lowering ASOs prolong survival in prion‑infected mice

448: PrP‑lowering ASOs prolong survival in prion‑infected mice

Raymond GJ et al., JCI Insight - This study tests antisense oligonucleotides (ASOs) targeting Prnp in wild‑type mice infected with RML prions and shows that sequence‑specific PrP lowering by bolus i.c...

23 Elo 25min

447: Divalent siRNA for prion disease

447: Divalent siRNA for prion disease

Gentile JE et al., Nucleic Acids Research - This study develops and tests divalent siRNA molecules that lower prion protein (PrP) in the brain, identifies a potent human-targeting candidate (2439-s4),...

23 Elo 23min

446: Cilia, Synuclein, and Survival: G51D Mice Reveal a Shared Parkinson’s Pathway

446: Cilia, Synuclein, and Survival: G51D Mice Reveal a Shared Parkinson’s Pathway

Lin Y‑E et al., PNAS - Knock‑in SncaG51D/G51D mice show selective loss of primary cilia in specific striatal interneurons, astrocytes, piriform cortex PV cells and olfactory basal stem cells, with con...

23 Elo 28min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
rss-poliisin-mieli
tiedekulma-podcast
rss-hereilla
rss-duodecim-lehti
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
docemilia
rss-bios-podcast
hippokrateen-vastaanotolla
mielipaivakirja
radio-antro
rss-radplus
rss-lihavuudesta-podcast
rss-ranskaa-raakana
rss-politiikasta-podcast